1. The differences in clinicopathological features and prognosis among the subtypes of signet ring cell, mucinous, papillary, and lymphoepithelioma-like carcinoma in advanced gastric cancer.
- Author
-
Kim KH, Kim MC, Jung GJ, and Kim SJ
- Subjects
- Adult, Aged, Anastomosis, Surgical, Carcinoma, Papillary secondary, Carcinoma, Papillary surgery, Carcinoma, Signet Ring Cell secondary, Carcinoma, Signet Ring Cell surgery, Female, Gastrectomy, Humans, Lymphoma surgery, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasms, Cystic, Mucinous, and Serous secondary, Neoplasms, Cystic, Mucinous, and Serous surgery, Retrospective Studies, Stomach Neoplasms surgery, Survival Analysis, Time Factors, Treatment Outcome, Carcinoma, Papillary pathology, Carcinoma, Signet Ring Cell pathology, Lymphoma pathology, Neoplasms, Cystic, Mucinous, and Serous pathology, Stomach Neoplasms pathology
- Abstract
Background/aims: There are differing histologic subtypes of gastric cancer. We investigated the clinicopathological features and prognosis of: signet ring cell (SRC), mucinous (MGC), papillary (PGC), and lymphoepithelioma-like (LELC) carcinoma in advanced gastric cancer., Methodology: One hundred thirty six advanced gastric cancer patients, including 62 SRCs, 43 MGCs, 9 PGCs, and 22 LELCs, who underwent R0 gastrectomy between 2002 and 2013, were retrospectively evaluated., Results: There were significant differences in several clinicopathological features. There were found to be statistical differences in postoperative outcomes in the type of gastrectomy and type of anastomosis (p<0.001 and p<0.001, respectively). In terms of overall survival analysis, there was no statistical survival difference among the subtypes of advanced gastric cancer (p=0.088). However, LELC had a better prognosis than the other groups., Conclusions: There were some differences in several of the clinicopathological features of the subtypes advanced gastric cancer. Although there were no statistical differences in survival, those with LELC showed a better prognosis than did the other groups. Therefore, the treatment of advanced gastric cancer should be individualized, and prognosis considered, according to the subtype.
- Published
- 2014